SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,305,000 | -16.7% | 17,429 | -3.7% | 0.01% | -20.0% |
| Q4 2020 | $1,566,000 | -41.3% | 18,098 | -58.6% | 0.02% | -48.3% |
| Q3 2020 | $2,669,000 | +203.0% | 43,671 | +106.2% | 0.03% | +163.6% |
| Q2 2020 | $881,000 | -89.2% | 21,177 | -92.5% | 0.01% | -92.0% |
| Q1 2020 | $8,150,000 | -58.0% | 283,786 | +5.6% | 0.14% | -49.3% |
| Q4 2019 | $19,400,000 | -48.1% | 268,733 | +0.9% | 0.27% | -52.0% |
| Q3 2019 | $37,356,000 | +1099.6% | 266,280 | +1465.7% | 0.56% | +157.8% |
| Q2 2019 | $3,114,000 | – | 17,007 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |